sample_id,Sample coverage,Tumor Purity,age_at_diagnosis,age_at_seq_reported_years,ethnicity,exon_number,gender,metastic_site,mitotic_rate,msi_score,msi_type,mutated_genes,note,order,os_months,os_status,patient_id,ped_ind,pre_therapy_group,primary_site,primary_site_group,race,recurrence_free_months,recurrence_status,sample_type,stage_at_diagnosis,tmb_nonsynonymous,treatment,treatment_details,treatment_duration_days,treatment_response,tumor_size,variant_type
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.07,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.07,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.07,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.07,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.07,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.07,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.07,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.07,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.07,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.133333333333,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.04,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.218310601,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.04,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.218310601,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
